Adema; Gosse Jan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Adema; Gosse Jan.The latest application filed is for "new potent sialyltransferase inhibitors".

Company Profile

0.5.22

Adema; Gosse Jan - Groesbeek NL
Adema, Gosse Jan - Nijmegen NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
New potent sialyltransferase inhibitors App 20210107931 - Boltje; Thomas Jan ; et al.	2021-04-15
Isolated Mammalian Monocyte Cell Genes; Related Reagents App 20140141444 - Adema; Gosse Jan ; et al.	2014-05-22
Isolated Mammalian Monocyte Cell Genes; Related Reagents App 20140141445 - Adema; Gosse Jan ; et al.	2014-05-22
Isolated Mammalian Monocyte Cell Genes; Related Reagents App 20130034561 - Adema; Gosse Jan ; et al.	2013-02-07
Isolated Mammalian Monocyte Cell Genes; Related Reagents App 20120020990 - Adema; Gosse Jan ; et al.	2012-01-26
Melanoma associated peptide analogues and vaccines against melanoma Grant 8,075,900 - Figdor , et al. December 13, 2	2011-12-13
Antibodies that bind DNAX leukocyte associated immunoglobulin-like receptor Grant 7,999,078 - Adema , et al. August 16, 2	2011-08-16
Melanoma Associated Peptide Analogues And Vaccines Against Melanoma App 20110135675 - Figdor; Carl Gustav ; et al.	2011-06-09
Melanoma associated peptide analogues and vaccines against melanoma Grant 7,846,450 - Figdor , et al. December 7, 2	2010-12-07
Mammalian Genes; Related Reagents and Methods App 20100261190 - Zlot; Constance H. ; et al.	2010-10-14
Isolated Mammalian Monocyte Cell Genes; Related Reagents App 20100209907 - Adema; Gosse Jan ; et al.	2010-08-19
Melanoma Associated Peptide Analogues And Vaccines Against Melanoma App 20090232839 - Figdor; Carl Gustav ; et al.	2009-09-17
Mammalian Genes: Related Reagents and Methods App 20090156786 - Zlot; Constance H. ; et al.	2009-06-18
Immunomodulation Of Dendritic Cells App 20090035300 - Adema; Gosse Jan ; et al.	2009-02-05
Antibodies that specifically bind to FDF03 App 20050287582 - Adema, Gosse Jan ; et al.	2005-12-29
Mammalian genes; related reagents and methods App 20050142587 - Zlot, Constance H. ; et al.	2005-06-30
Isolated mammalian monocyte cell genes; related reagents App 20050059808 - Adema, Gosse Jan ; et al.	2005-03-17
Melanoma associated peptide analogues and vaccines against melanoma App 20040156861 - Figdor, Carl Gustav ; et al.	2004-08-12
Isolated mammalian monocyte cell genes; related reagents App 20040143858 - Adema, Gosse Jan ; et al.	2004-07-22
Renal cell carcinoma-antigen G250-derived peptides that elicit both CD4+ and CD8+ T-cell responses App 20040053391 - Vissers, Joost Lambert Max ; et al.	2004-03-18
Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma App 20030216559 - Adema, Gosse Jan ; et al.	2003-11-20
Isolated mammalian monocyte cell genes; related reagents App 20030105303 - Adema, Gosse Jan ; et al.	2003-06-05
Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma Grant 6,500,919 - Adema , et al. December 31, 2	2002-12-31
Antibodies that specifically bind DNAX leukocyte associated immunoglobulin-like receptor Grant 6,479,638 - Adema , et al. November 12, 2	2002-11-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.